XTalks

NOVEMBER 9, 2023

Abbott’s molecular human papillomavirus (HPV) screening solution has received approval from the US Food and Drug Administration (FDA) for detecting high-risk HPV infections and as a primary cervical cancer screening tool. The HPV test is an addition to Abbott’s Alinity m diagnostic assay family.

FDA Approval 64

FDA Approval HR Genotype Life Science 64

World of DTC Marketing

JANUARY 24, 2022

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8

Life Science 225

Life Science Drugs Genetic Disease Development 225

XTalks

SEPTEMBER 28, 2023

While digital media, such as short video formats on social media platforms, is being adopted by many segments and industries, pharma advertising remains more traditional, with print and TV advertising continuing to be favored by pharma companies. Outside of pharma, the list included new ads from Revlon and mobile games Dream.

Drugs 105

Drugs Allergies Branding FDA Approval 105

XTalks

DECEMBER 27, 2022

Ferring Pharmaceuticals announced that the US Food and Drug Administration (FDA) approved Adstiladrin (nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors.

Gene Therapy 52

Gene Therapy FDA Approval Gene Clinical Trials 52

XTalks

AUGUST 21, 2023

The US Food and Drug Administration (FDA) has approved Ipsen’s groundbreaking Sohonos (palovarotene) capsules for the treatment of fibrodysplasia ossificans progressive (FOP), an ultra-rare bone disease. The median life expectancy of patients with FOP is 56, making it a severe and often misdiagnosed disease.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

XTalks

MAY 31, 2024

Allecra Therapeutics, a clinical-stage biopharma company focused on combating antibiotic resistance, received approval from the US Food and Drug Administration (FDA) for Exblifep (cefepime/enmetazobactam). The FDA has set a Prescription Drug User Fee Act (PDUFA) action date of October 25, 2024.

Bacteria 52

Bacteria FDA Approval Trials Pharma Companies 52

XTalks

NOVEMBER 2, 2023

Amgen’s Wezlana (ustekinumab-auub) has received US Food and Drug Administration (FDA) approval as a Stelara biosimilar for the treatment of several inflammatory diseases including Crohn’s disease, ulcerative colitis (UC), plaque psoriasis and psoriatic arthritis.

FDA Approval 59

FDA Approval Production Dermatology Sales 59

XTalks

AUGUST 18, 2020

SalivaDirect, a saliva-based COVID-19 test that was tested among players of the National Basketball Association (NBA), has been given emergency use authorization (EUA) by the US Food and Drug Administration (FDA). Last month, the FDA approved a pooled test for COVID-19 developed by Quest Diagnostics. It’s sensitive.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. In that time, we’ve gone from running 25 webinars each year to over 400, working with more than 800 expert speakers each year.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

XTalks

FEBRUARY 14, 2024

Nonetheless, the hearing did highlight important facts and problems about drug pricing in the US, putting the pharma CEOs in the hot seat. Sanders pointed out GoFundMe pages that patients had to set up to try to afford expensive drugs. No apologies, no promises and no acceptance of any wrongdoings. went on for over three hours.

Drugs 52

Drugs Insulin Pharmacy Development 52

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. He has worked on Visensia, the world’s first FDA-approved multivariate patient monitoring system, and the SEND system, which is now used to monitor 20,000 patients each month in the NHS.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

pharmaphorum

MARCH 2, 2022

Ben Hargreaves discovers why medical research in the area has shifted from being highly controversial to being backed by major pharma companies and venture capital. The image of psychedelic drugs within medical research is changing. A psychedelic renaissance.

Life Science 105

Life Science Clinical Trials Clinical Trials Trials 105

XTalks

JUNE 25, 2024

In the past two years, the industry has faced considerable challenges due to a constrained financing environment, forcing many emerging and early-stage biotech companies to restructure their operations, merge with other companies or narrow their research and development (R&D) efforts by shelving certain assets. billion in 2023.

Pharma Companies 52

Pharma Companies Production FDA Approval Vaccination 52

XTalks

MARCH 29, 2022

According to a press release from Jazz Pharma, the plant has a planned opening date in 2024 and will welcome 100 new employees. The 60,000-square-foot facility was specially designed to support the company’s two regulatory-approved cannabis-based medicines and offer capacity for future drugs currently under development.

Medicine 111

Medicine Manufacturing Sales FDA Approval 111

XTalks

FEBRUARY 21, 2024

Recently, Eli Lilly revealed promising results from a mid-stage trial, indicating that its popular drug, tirzepatide (marketed as Zepbound and Mounjaro for weight loss and diabetes, respectively), may be an effective treatment for the fatty liver disease metabolic dysfunction-associated steatohepatitis (MASH).

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

pharmaphorum

AUGUST 31, 2021

However, like many other emerging healthcare technologies, they have been slow to gain traction and there is still confusion and scepticism around ECAs, stemming from a lack of precedence, step-by-step guidance and data to quantify their impact on drug development costs and clinical outcomes.

Clinical Trials 89

Clinical Trials Clinical Trials Life Science Trials 89

XTalks

JANUARY 4, 2024

Some Investigational New Drugs in Clinical Trials for Glaucoma Skye Bioscience is a pharma company dedicated to developing a synthetic cannabinoid derivative for glaucoma treatment. Aerpio Pharmaceuticals’ investigational drug razuprotafib, also known as AKB-9778, is being evaluated as a potential treatment for OAG and OHT.

Clinical Trials 59

Clinical Trials Clinical Trials FDA Approval Trials 59

XTalks

MAY 29, 2024

Here, we will deep-dive into the top five fastest growing pharma and biotech companies in 2024, showcasing their innovative strategies and inspiring achievements. Pfizer (Overall Rank 268) Leading the list is one of the most renowned pharma companies in the world: Pfizer.

Medicine 52

Medicine Marketing FDA Approval Development 52

pharmaphorum

DECEMBER 23, 2020

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. The results also suggest further uses for the drug in early disease and more revenues to come from one of the company’s biggest success stories from the last decade.

Marketing 96

Marketing Gene Silencing Gene Drugs 96

XTalks

MAY 25, 2021

AbbVie (NYSE:ABBV) continues to face heat over complaints of patent exploitation and price hikes of its world’s best-selling drug Humira (adalimumab) to build a market monopoly and block out Humira biosimilar competition. A recent congressional probe provided confirmation of the claims. Biosimilars. Humira Biosimilars: Alvotech Lawsuit.

Production 98

Production Drugs Marketing Sales 98

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. About the author.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

Cloudbyz

MAY 19, 2021

Introduction Cell and gene therapy is an upcoming wave of therapeutic innovation in the healthcare and life sciences industry and is being pragmatically accepted worldwide. The gene therapy market reported its first market approvals back in 2017 and the evolution has been extensive ever since.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

Delveinsight

AUGUST 4, 2021

In June 2021, Aducanumab by Biogen received FDA approval to treat patients with Alzheimer’s disease. Similarly, other companies in the domain such as Eisai/ BioArctic AB, Hoffmann-La Roche/Chugai Pharmaceuticals, Anavex Life Sciences Corp., and Neurimmune are actively working in the Alzheimer’s Therapeutics Market.

Marketing 98

Marketing Genetics Development Clinical Development 98

Pharmaceutical Technology

FEBRUARY 13, 2023

Although recently approved drugs can treat seizures more safely, they do not treat the comorbidities that patients experience. Several biotech companies and researchers are now exploring medical devices and gene therapies to address not just common forms of epilepsy, but also rare conditions such as Dravet Syndrome.

Research 264

Research Gene Gene Therapy Genome 264

XTalks

AUGUST 17, 2020

Immune checkpoint inhibitors : these are drugs that block immune checkpoints, allowing immune cells to elicit enhanced responses to cancer cells. In 2017, the US FDA approved a CAR-T cell treatment for young adults and children with B-cell ALL. There is therefore a breadth of opportunity with this drug says Dr. Suri.

Protein 98

Protein Engineer Immune Response In-Vivo 98